Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation
Increasing consent rates for organ donation and making the most of donated organs for transplant […]
STRIDES Study Reaches Million-donor Milestone
The NHS Blood and Transplant (NHSBT) blood donor management research project, STRIDES, now has more […]
NHSBT: First Blood Plasma for Medicines Donations Begin
NHS Blood and Transplant (NHSBT) will from today take donations at 14 donor centres around […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more